logo

Exhibiting at Fi North America | Supply Side West 2024

Mandalay Bay, Las Vegas
30 Oct - 31 Oct, 2024

Product Offerings

Product Categories:

Cardiovascular, Respiratory, Oncology, Hormones, Urology

Products:

Effervescent Tablets, MDIs, Nasal Sprays, Hormone Products, Granules

Founded in 1980, Synmosa Biopharma Corporation is a specialty pharmaceutical company based in Taiwan. The company is dedicated to the development, manufacturing, and distribution of pharmaceutical products across several therapeutic areas, including cardiovascular, respiratory, oncology, urology, and hormone therapies. Synmosa has built its reputation by focusing on high-value niche markets and utilizing advanced technology platforms such as metered dose inhalers (MDIs), effervescent tablets, and hormone therapies. With a strong presence in Taiwan, China, and other Asian markets, Synmosa is committed to expanding its global footprint through innovation and strategic alliances.